Changes in schizophrenia diagnoses associated with cannabis use disorder

Original Article ↗ Hacker News Discussion ↗

Subjective Effects and Individual Variability

  • Many describe wildly different reactions: from “almost nothing but mild dissociation” to intense anxiety, derealization, and panic after very small doses.
  • Some can’t tolerate smoking or vaping physically (coughing, choking), and find edibles/tinctures inconsistent or weak; others note that 5 mg is a strong dose for non-tolerant users and products are often mislabeled.
  • Several suggest expectations and prior psychedelic experience shape perception: weed may feel trivial compared with LSD-level hallucinations.
  • There is speculation about whether differences are psychological (interpretation of dissociation) or physiological (different sensitivity/receptors), but this remains unclear.

Psychosis, Schizophrenia, and Risk

  • Multiple anecdotes of heavy or daily use leading to hallucinations, delusional thinking, extreme paranoia, and near-complete schizophrenia symptom clusters, which often improved after quitting.
  • Others report clear psychotic episodes directly after cannabis, enough to stop using altogether.
  • Several commenters highlight that early heavy use appears especially risky for people genetically predisposed to schizophrenia; delaying or minimizing use before mid‑20s is framed as prudent.
  • Some note that cannabis and LSD can trigger a first psychotic break that may become permanent, especially in vulnerable individuals.

Interpreting the Study: Correlation, Causality, and Diagnosis

  • Quoted study result: schizophrenia incidence stayed stable post‑legalization, while “psychosis NOS” diagnoses increased substantially.
  • Explanations debated:
    • Cannabis may worsen or unmask existing vulnerabilities.
    • More users → more psychotic patients who happen to use cannabis, without direct causation.
    • Some psychotic individuals may use cannabis or nicotine as self-medication.
  • There is concern about misdiagnosis and spectrum thinking (not simply “schizophrenic vs. not”), but several believe the clinical pattern of cannabis worsening psychosis is “something real,” even if mechanisms are unclear.
  • Commenters emphasize that ethical and practical limits make rigorous randomized or double‑blind causality studies hard or impossible.

Cannabis vs. Alcohol and Other Substances

  • Strong disagreement on relative harm: some call cannabis “one of the least toxic” and see psychosis risk as minor compared to alcohol’s death toll; others stress that heavy cannabis clearly impairs cognition, motivation, and social functioning in many.
  • Shared view: both should be legal but honestly presented as risky, especially for youth and for people with family histories of psychosis or addiction.

Broader Cognitive and Social Effects

  • Reports of chronic use leading to demotivation, memory problems, emotional blunting, and withdrawal, with gradual reversal after prolonged abstinence.
  • Several describe cannabis fostering “aberrant salience”: over-attributing meaning and patterns, often feeding conspiracy thinking or grandiose “secret insight” feelings.
  • General consensus: occasional use can be enjoyable for some, but habitual or heavy use is not harmless and is especially ill-advised for already anxious or unstable individuals.